Product Description
Avian Influenza A H7N9 Neuraminidase Antibody | 7831 | ProSci
Host: Rabbit
Reactivity: Virus
Homology: N/A
Immunogen: Avian Influenza A H7N9 Neuraminidase antibody was raised against a synthetic peptide corresponding to 11 amino acids near the amino terminus of the H7N9 [Influenza A virus (A/blue-winged teal/Ohio/566/2006 (H7N9) ) ] Neuraminidase protein.
The immunogen is located within amino acids 50 - 100 of Avian Influenza A H7N9 Neuraminidase.
Research Area: Infectious Disease
Tested Application: E
Application: Avian Influenza A H7N9 Neuraminidase antibody can be used for detection of Avian Influenza A H7N9 Neuraminidase by ELISA at 1 μg/ml.
Specificiy: virus
Positive Control 1: N/A
Positive Control 2: N/A
Positive Control 3: N/A
Positive Control 4: N/A
Positive Control 5: N/A
Positive Control 6: N/A
Molecular Weight: N/A
Validation: N/A
Isoform: N/A
Purification: Avian Influenza A H7N9 Neuraminidase antibody is affinity chromatography purified via peptide column.
Clonality: Polyclonal
Clone: N/A
Isotype: IgG
Conjugate: Unconjugated
Physical State: Liquid
Buffer: Avian Influenza A H7N9 Neuraminidase Antibody is supplied in PBS containing 0.02% sodium azide.
Concentration: 1 mg/mL
Storage Condition: Avian Influenza A H7N9 Neuraminidase antibody can be stored at 4˚C for three months and -20˚C, stable for up to one year.
Alternate Name: Avian Influenza A H7N9 Neuraminidase Antibody:
User Note: Optimal dilutions for each application to be determined by the researcher.
BACKGROUND: Influenza A virus is a major public health threat, killing more than 30, 000 people per year in the USA (1) . Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found (2) . These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3) .